ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALVO Alvontech

13.22
0.33 (2.56%)
Apr 19 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,686,575
Bid Price 12.50
Ask Price 13.53
News (1)
Day High 14.00

Low
6.70

52 Week Range

High
18.00

Day Low 12.75
Share Name Share Symbol Market Stock Type
Alvontech ALVO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.33 2.56% 13.22 17:00:06
Open Price Low Price High Price Close Price Previous Close
13.30 12.75 14.00 13.22 12.89
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,816 1,686,575 US$ 13.47 US$ 22,711,095 - 6.70 - 18.00
Last Trade Type Quantity Price Currency
15:01:46 55 US$ 13.53 USD

Alvontech Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.49B 263.51M - 93.38M -551.73M -2.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Alvontech News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ALVO Message Board. Create One! See More Posts on ALVO Message Board See More Message Board Posts

Historical ALVO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week11.7914.0011.1912.55246,9021.4312.13%
1 Month15.0015.03511.010112.33174,857-1.78-11.87%
3 Months14.2518.0011.010115.19284,480-1.03-7.23%
6 Months8.6518.008.0014.33194,8244.5752.83%
1 Year10.2518.006.7012.80134,8742.9728.98%
3 Years9.5018.005.2011.94111,6633.7239.16%
5 Years9.5018.005.2011.94111,6633.7239.16%

Alvontech Description

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. The company's purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Your Recent History

Delayed Upgrade Clock